The absence of prior notice of mergers may result in significant fines without breaching the principle of proportionality
A series of judgments recently handed down by national and European authorities and courts has recalled the high financial consequences that may be borne by companies that have failed to notify and have implemented their merger without authorisation from the competent competition authority.
For the record, the commission can impose fines of up to 10 per cent of the total turnover of the companies concerned. In France, the fine imposed by the Competition Authority can be as much as five per cent of the turnover recorded by the buyer in France, increased by, as the case may be, the turnover recorded by the target in France during the same period. These sanctions are incurred even if the transaction is later authorised by the competent authorities. This implies that companies must evaluate whether their transaction requires a control by competition authorities, which can sometimes be complex, especially when acquiring a minority shareholding…
Click on the link below to read the rest of the Dentons briefing.
Sign in or Register to continue reading this article
It's quick, easy and free!
It takes just 5 minutes to register. Answer a few simple questions and once completed you’ll have instant access.Register now
Why register to The Lawyer
In-depth, expert analysis into the stories behind the headlines from our leading team of journalists.
Identify the major players and business opportunities within a particular region through our series of free, special reports.
Receive your pick of The Lawyer's daily and weekly email newsletters, tailored by practice area, region and job function.
More relevant to you
To continue providing the best analysis, insight and news across the legal market we are collecting some information about who you are, what you do and where you work to improve The Lawyer and make it more relevant to you.
News from Dentons
News from The Lawyer
Briefings from Dentons
In January and February the CMA is conducting site visits, visiting a number of parties to the investigation to find out how they carry on their business and differentiate their offers.
Hedge fund manager Kyle Bass plans to take on some of the world’s largest drug producers by challenging the patents that protect their top products.
Analysis from The Lawyer
Life in Canada is getting harder for firms as commodities prices fall and work volumes slow
Which firms are cutting it in this era of slimline rosters, and who are the GC new brooms making clean sweeps? The Lawyer can reveal all